Evidence map›Paper›PMID 39369404›Full record

ArticleJNMA; journal of the Nepal Medical Association2024

Levamisole Induced Agranulocytosis in a Child with Steroid Dependent Nephrotic Syndrome: A Case Report.

Mohammad Firoz Anjum, Gaurav Kumar Gupta, Jeetendra Bhandari

Abstract readCase Reports
In one paragraph

Article in JNMA; journal of the Nepal Medical Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Mohammad Firoz AnjumPatan Academy of Health Sciences, Lagankhel, Lalitpur, Nepal.
Gaurav Kumar GuptaNarayani Upachetriya Hospital, Birjung, Nepal.
Jeetendra BhandariKarnali Academy of Health Sciences, Jumla, Nepal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

abstractLevamisole has been used as an effective immunomodulator. Levamisole has been used for nephrotic syndrome due to its immunostimulant, immunomodulating, and steroid-sparing effects. Common adverse effects of levamisole are gastrointestinal symptoms (nausea, abdominal cramps), and pyrexia. However, agranulocytosis or pancytopenia is also a rare but life-threatening complication of levamisole. This is a case report of a 5-year-old girl who had steroid-dependent nephrotic syndrome for which she was started on levamisole as per her weight, following which she had falling total leukocyte count levels on every visit. Thus, this case report emphasizes identifying this rare side effect and its management.

Indexed as

Adjuvants, ImmunologicAgranulocytosisLevamisoleNephrotic SyndromeChild, PreschoolFemaleHumansAdjuvants, ImmunologicLevamisoleagranulocytosis; immunomodulator; levamisole; steroid-dependent nephrotic syndrome.

Identifiers

PMID39369404
PMCPMC11455650

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.